Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Greenwich Global Hedge Fund Index shed -0.21% in March (+4.4% YTD)

Tuesday, April 24, 2012
Opalesque Industry Update - The Greenwich Global Hedge Fund Index (“GGHFI”) shed 0.21% compared to global equity returns of +3.29% for the S&P 500 Total Return index and +1.02% for the MSCI World Equity index. Hedge fund managers were given the chance to highlight their abilities in March, as bifurcated markets produced divergent results among strategies. Although 53% of constituent funds in the GGHFI ended the month with gains, the GGHFI declined marginally as Short-biased, Futures and Macro strategies produced negative returns.

“March was an interesting month for hedge funds as several strategies saw wide dispersions of returns across managers. Long-Short Equity funds with overweight positions in technology stocks performed exceptionally well while others that expected more of a market correction lagged their benchmarks. Market Neutral funds continued to demonstrate their performance and diversification benefits; both Event-Driven and Arbitrage focused managers gained for the third straight month this year. The Greenwich Investable Indices also enjoyed a successful March, with the Composite and Long-Short Indices outpacing their Global Index benchmarks,” notes Clint Binkley, Senior Vice President...Full performance table: Source
PD

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its